South Korea's Daewoo Shipbuilding & Marine Engineering Co. suffered a net loss of 29.2 billion won in the third quarter despite robust operating profit due to a 50 billion won loan to a subsidiary written off in its books as a loss.
The net loss shrank from 296.4 billion last year.
Operating profit came to 33.6 billion won in the third period, a turnaround from an operating loss of 256.3 billion won, while sales fell 26 percent to 1.44 trillion won.
In the first nine months of the year, sales came in at 5.37 trillion won and operating profit was 386 billion won. Net profit stood at 264.8 billion won.
The company added that its debt-to-equity ratio decreased to 161.4 percent in the third quarter from 200.3 percent at the end of 2019.
Weak orders due to the pandemic decreased its order backlogs.


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



